Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Looker, Katharine J ^a   Magaret, Amalia S ^b   Turner, Katherine M E ^a   Vickerman, Peter ^a   Gottlieb, Sami L ^c   Newman, Lori M ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICA; AGE DISTRIBUTION; ARTICLE; BIOASSAY; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POPULATION SIZE; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; VIRUS TRANSMISSION; HERPES GENITALIS; MIDDLE AGED; THEORETICAL MODEL; UNCERTAINTY;

HERPES VACCINE;

ADOLESCENT; ADULT; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HERPESVIRUS VACCINES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, THEORETICAL; PREVALENCE; UNCERTAINTY;

EID: 84950111019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114989     Document Type: Article

References (50)

1. Gupta R, Warren T, Wald A (2007) Genital herpes. Lancet 370:2127-2137.
2. (2010) Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States, 2005-2008. MMWR Morb Mortal Wkly Rep 59:456-459.
3. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, et al. (1997) The acquisition of herpes simplex virus during pregnancy. N Engl J Med 337:509-515.
4. Pinninti SG, Kimberlin DW (2013) Maternal and neonatal herpes simplex virus infections. Am J Perinatol 30:113-119.
5. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, et al. (2006) Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20:73-83.
6. Brown JM, Wald A, Hubbard A, Rungruengthanakit K, Chipato T, et al. (2007) Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS 21:1515-1523.
7. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, et al. (2003) Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 187:1513-1521.
8. Todd J, Riedner G, Maboko L, Hoelscher M, Weiss HA, et al. (2013) Effect of genital herpes on cervicovaginal HIV shedding in women co-infected with HIV AND HSV-2 in Tanzania. PLoS One 8:e59037.
9. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, et al. (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357:1149-1153.
10. Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, et al. (2010) Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 375:824-833.
11. Schacker T, Zeh J, Hu HL, Hill E, Corey L (1998) Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 178:1616-1622.
12. Augenbraun M, Feldman J, Chirgwin K, Zenilman J, Clarke L, et al. (1995) Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 123:845-847.
13. Wald A, Link K (2002) Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 185:45-52.
14. Kenyon C, Colebunders R, Hens N (2013) Determinants of generalized herpes simplex virus-2 epidemics: the role of sexual partner concurrency. Int J STD AIDS 24:375-382.
15. Celum C, Wald A, Hughes J, Sanchez J, Reid S, et al. (2008) Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, doubleblind, placebo-controlled trial. Lancet 371:2109-2119.
16. Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, et al. (2008) Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 358:1560-1571.
17. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, et al. (2010) Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362:427-439.
18. Belshe RB, Leone PA, Bernstein DI, Wald A, Levin MJ, et al. (2012) Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 366:34-43.
19. Genocea website. Genocea Announces Positive Top-Line 12-Month Follow-up Data from Phase 1/2a Clinical Trial for HSV-2 Immunotherapy GEN-003. Available: http://irgenoceacom/releasedetailcfm?ReleaseID5857313 Accessed 2014 Nov. 12.
20. Agenus website. Agenus Vaccine Shows Significant Reduction in Viral Burden after HerpV Generated Immune Activation. Available: http://investoragenusbiocom/press-release/agenus-vaccine-showssignificantreduction-viral-burden-after-herpv-generated-immune-A Accessed 2014 Nov. 12.
21. Johnston C, Koelle DM, Wald A (2014) Current status and prospects for development of an HSV vaccine. Vaccine 32:1553-1560.
22. Broutet N, Fruth U, Deal C, Gottlieb SL, Rees H (2014) Vaccines against sexually transmitted infections: the way forward. Vaccine 32:1630-1637.
23. Looker KJ, Garnett GP, Schmid GP (2008) An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ 86:805-812, A.
24. Smith JS, Robinson NJ (2002) Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186 Suppl 1:S3-28.
25. Morrow R, Friedrich D (2006) Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection. Clin Microbiol Infect 12:463-469.
26. Kelsey JL, Thompson WD, Evans AS (1986) Methods in Observational Epidemiology (Monographs in Epidemiology & Biostatistics): Oxford University Press.
27. Ashley RL (2001) Sorting out the new HSV type specific antibody tests. Sex Transm Infect 77:232-237.
28. Muench H (1959) Catalytic models in epidemiology. Harvard University Press.
29. United Nations (2013) World Population Prospects: The 2012 Revision. 2013 ed. New York, 2013: United Nations, Department of Economic and Social Affairs, Population Division.
30. Ashley-Morrow R, Nollkamper J, Robinson NJ, Bishop N, Smith J (2004) Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 10:530-536.
31. World Health Organization website. Global incidence and prevalence of selected curable sexually transmitted infections - 2008. Geneva, World Health Organization, 2012. http://appswhoint/iris/bitstream/10665/75181/1/9789241503839-engpdf?ua51 Accessed 2014 May 30.
32. Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit J, et al. (2008) Sexually Transmitted Diseases; Chapter 24: Genital Herpes: McGraw-Hill Medical.
33. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, et al. (2004) Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350:11-20.
34. Kaushic C, Roth KL, Anipindi V, Xiu F (2011) Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses. J Reprod Immunol 88:204-209.
35. Glynn JR, Carael M, Auvert B, Kahindo M, Chege J, et al. (2001) Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia. AIDS 15 Suppl 4:S51-60.
36. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, et al. (1997) Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337:1105-1111.
37. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, et al. (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296:964-973.
38. Abu-Raddad LJ, Schiffer JT, Ashley R, Mumtaz G, Alsallaq RA, et al. (2010) HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa. Epidemics 2:173-182.
39. Ashley RL, Eagleton M, Pfeiffer N (1999) Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J Clin Microbiol 37:1632-1633.
40. Ashley-Morrow R, Krantz E, Wald A (2003) Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis 30:310-314.
41. Tassiopoulos KK, Seage G 3rd, Sam N, Kiwelu I, Shao J, et al. (2007) Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania. J Infect Dis 195:493-501.
42. Pena KC, Adelson ME, Mordechai E, Blaho JA (2010) Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States. J Clin Microbiol 48:150-153.
43. Roberts CM, Pfister JR, Spear SJ (2003) Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 30:797-800.
44. Tuokko H, Bloigu R, Hukkanen V (2014) Herpes simplex virus type 1 genital herpes in young women: current trend in Northern Finland. Sex Transm Infect.
45. Gray E, Morgan J, Lindeman J (2008) Herpes simplex type 1 versus Herpes simplex type 2 in anogenital herpes; a 10 year study from the Waikato region of New Zealand. N Z Med J 121:43-50.
46. Ryder N, Jin F, McNulty AM, Grulich AE, Donovan B (2009) Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992-2006. Sex Transm Infect 85:416-419.
47. Mercer CH, Tanton C, Prah P, Erens B, Sonnenberg P, et al. (2013) Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet 382:1781-1794.
48. Wald A, Ashley-Morrow R (2002) Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin Infect Dis 35:S173-182.
49. Benedetti J, Corey L, Ashley R (1994) Recurrence rates in genital herpes after symptomatic firstepisode infection. Ann Intern Med 121:847-854.
50. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, et al. (2003) Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289:203-209.